Effectiveness of integrative medicine for preventing postoperative recurrence of primary hepatic carcinomas: a systematic review.
- Author:
Zi-yao CHEN
;
Jian LIANG
;
Xin DENG
- Publication Type:Journal Article
- MeSH: Drugs, Chinese Herbal; therapeutic use; Humans; Integrative Medicine; Liver Neoplasms; prevention & control; Neoplasm Recurrence, Local; prevention & control; Postoperative Period; Randomized Controlled Trials as Topic; Treatment Outcome
- From: Chinese Journal of Integrated Traditional and Western Medicine 2014;34(6):671-675
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo systematically evaluate the effectiveness of integrative medicine (IM) for preventing postoperative recurrence of primary hepatic carcinomas (PHC).
METHODSSuch databases as The Cochrane Library, PubMed, EMbase, China National Knowledge Infrastructure (CNKI), VIP Database, Wan-fang Database were retrieved to collect randomized controlled trials (RCTs) on preventing postoperative recurrence of PHC by IM. The retrieval period started from database establishment to June 2013. Literature screening, data extraction, and quality evaluation were performed by two reviewers strictly according to inclusion criteria. Meta-analysis was conducted using RevMan 5.2 Software.
RESULTSA total of 5 RCTs involving 367 patient cases were included. Results of Meta-analysis showed that the IM group was superior to the Western medicine (WM) group in the 1-, 2-, and 3-year recurrence rates (P < 0.05).
CONCLUSIONIn the prevention of postoperative recurrence of PHC, the effectiveness of IM was more significant, when compared with treatment of Western medicine.